Anteo Diagnostics Ltd has released a press release.
AnteoTech: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- Quarterly Activities/Appendix 4C Cash Flow Report
- AnteoTech $3.5m Capital Raising
- Trading Halt
- AnteoBind order received and Life Sciences Update
- Ultranode X achieves more than 1,000 Cycles at 80% Capacity
Later from AnteoTech
- Ultranode 95 validated in cell format suited for drone use
- Underwriting of Listed Options
- New Product- Anteo C - launched and Shipped for Scale Trials
- Anteo S Strategic Collaboration and Sales Agreement Executed
- Appendix 4E and Unaudited Financial Statements
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech